ARCHIVES

NCCN Guidelines Retain Avastin For Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

March 12, 2010

Votrient Trial Meets PFS Endpoint In Epithelial Ovarian Cancer

June 28, 2013

NCI advisors approve $50 million pilot for Human Cancer Genome Project; NHLBI Director Collins calls it a “unique, historic opportunity.”

November 18, 2005

Response Oncology Sells Practice Back To Physicians.

March 2, 2001

In Congress: Senate, House Reports List Priorities For NCI

August 8, 1997

Perot Systems To Provide IT Support For US Oncology Enterprise Applications.

December 15, 2000